NAMSA locks down buyer in ArchiMed

Concluding an Edgemont Partners sale process, the European suitor emerges with a deal that leaves management with an approximately 20% stake in the medical device services company.

27 August 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles